Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

Climate Asset Management has raised more than $1 billion to invest in natural capital projects such as regenerative agriculture, its chief executive told Reuters.

As the 10th anniversary of the Make in India initiative nears, CNBC’s Inside India takes a look at how the nation’s ...

Plus, news about GSK, Novo Nordisk, Tanai Therapeutics, Nomic Bio, Brenus Pharma, Xspray, Achilles Therapeutics, BioXcel Therapeutics and Nuvalent: Ascendis’ $300M offering: The Danish company ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

As China battles CNC technology restrictions, First Automation’s approach could offer the breakthrough the industry needs.

Japan's health ministry has accepted for review a new drug application (NDA) for GSK's Blenrep blood cancer treatment, marking the third major regulatory filing acceptance for the drug.

PHILADELPHIA, Sept. 16, 2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) is partnering with Brooke Shields, as part of its THRIVE@50+ campaign, to encourage people 50 and older to embrace and protect the ...

China is a linchpin in pharma’s global supply chain ... Eli Lilly has tapped WuXi Apptec to produce some of the ingredients in its blockbuster GLP-1 obesity medications, while GSK inked a licensing ...